Daily Archives: June 28, 2005

Featured Stories

Actos Whistleblower Lawsuit Questions Avandia Researcher's Financial Ties to Takeda

A prominent researcher has been implicated in an alleged cover-up of Actos side effects, according to a report from TheHeart.org. An Actos whistleblower lawsuit unsealed earlier this year has alleged financial connections between the Cleveland Clinic’s Dr Steven Nissen and the maker of Actos “should be considered when analyzing Actos’s ...

Read More

New York Property Owners Challenge Binghamton Fracking Ban

According to a Reuters report, the landowners believe the Binghamton, N.Y., city council and Mayor acted against proper protocol when voting to ban fracking drilling the the city. Instead, they feel the city should have consulted with the Broome County Planning Commission before approving the ban.

Read More

Conspiracy Claims in Talcum Powder Case Survive Motion to Dismiss

Conspiracy Claims in Talcum Powder Case Survive Motion to Dismiss

E. District of Missouri denied motion to dismiss conspiracy claims. Lawsuit alleges the defendants conspired to misrepresent true dangers with use of talcum powder.

Read More

Image Source: wisegeek.com

Trial over Ethicon Transvaginal Mesh Begins in California

Pelvic mesh devices have become the subject of safety concerns in recent years amidst reports that they can cause serious, sometimes permanent injuries.

Read More

Government Penalizes 721 Hospitals for High Rates of Infections, Injuries

Medicare is reducing payments to 721 hospitals, one out of every seven hospitals in the nation, for having high rates of “hospital-acquired” conditions (HAC.

Read More

FDA Warning for Bone Graft Products in Patients Under 18

FDA Safety Warning for Bone Graft Products in Patients Under 18

FDA issued safety alerts to patients, parents & guardians, bone graft devices w/recombinant proteins or synthetic peptides not to be the first treatment for 18 & under.

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

Indiana Woman Alleges Serious Injuries From Transvaginal Mesh Products

Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a woman who suffered injuries after receiving transvaginal mesh implants. The lawsuit suit alleges that the transvaginal mesh created an unreasonable risk and directly caused her injuries.

Read More

Scientist Calls for Federal Regulations for Fracking Pollution

Hydraulic fracturing (fracking) drilling should be governed by federal regulations because its pollution has no awareness of state boundaries.

Read More

EXPERT INDICATES THAT A GROWING NUMBER OF PREADOLESCENT GIRLS NOW ENGAGE IN DIETING AND OTHER BODY-CONSCIOUS BEHAVIORS AND MAY BE AT RISK FOR DEVELOPING SERIOUS EATING DISORDERS

Dr. Terry Bravender, assistant professor of pediatrics at Duke University Medical Center in Durham, North Carolina, and medical director of Duke Eating Disorder Program, sees an alarming trend with respect to the eating habits and concerns about body image in … Continue reading

Posted in Legal News |

NEWLY APPROVED TEST IDENTIFIES PATIENTS AT RISK FOR IMPENDING ìMAJOR ADVERSE CARDIAC EVENTSî

On May 10, the FDA approved an application by Prognostix, Inc. of Cleveland, Ohio, to market (to doctors) a test kit known as the CardioMPO which, in clinical trials, proved quite accurate in predicting which patients were at risk to … Continue reading

Posted in Legal News |

THE CONSUMER PROTECTION SAFETY COMMISSION (CPSC) ANNOUNCES ROSE ART INDUSTRIES TO PAY $300,000 PENALTY FOR FAILING TO REPORT SERIOUS BURN HAZARD TO CHILDREN FROM SOAP MAKING KIT

The CPSC has announced the following provisional settlement with Rose Art Industries, a toy and art materials manufacturer, for failing to report important product safety information to the Commission. The settlement will impose a $300,000 penalty against Rose Art, of … Continue reading

Posted in Defective Products |

COMPLAINTS MADE TO JAPANESE PROSECUTORS AGAINST ASTRAZENECA BY FAMILIES OF CANCER PATIENTS WHO DIED AFTER TAKING THE LUNG CANCER DRUG IRESSA

Iressa (gefitinib) was approved by the FDA on May 5, 2003 “as a single agent treatment for patients with advanced non-small cell lung cancer (NSCLC), the most common form of lung cancer in the U.S. Iressa was reviewed and approved … Continue reading

Posted in Legal News |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.